Stress ulcer prophylaxis in patients being weaned from the ventilator in a respiratory care center: A randomized control trial

Journal of the Formosan Medical Association

Volumn 115, Issue 1, 2016, Pages 19-24

  Lin, Chien Chu ^a   Hsu, Yeong Long ^a   Chung, Chen Shuan ^a,b   Lee, Tzong Hsi ^a  

^a FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^b FU JEN CATHOLIC UNIVERSITY   (Taiwan)

Author keywords

Lansoprazole OD; Proton pump inhibitor; Respiratory care center; Stress ulcer prophylaxis; Weaning

Indexed keywords

LANSOPRAZOLE; PROTON PUMP INHIBITOR;

AGED; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GASTROINTESTINAL ENDOSCOPY; HEMORRHAGIC GASTRITIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MECHANICAL VENTILATOR; NASOGASTRIC TUBE; OUTCOME ASSESSMENT; PEPTIC ULCER; PROPHYLAXIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REFLUX ESOPHAGITIS; STRESS ULCER; STRESS ULCER PROPHYLAXIS; SURVIVAL RATE; UPPER GASTROINTESTINAL BLEEDING; VENTILATOR ASSOCIATED PNEUMONIA; MIDDLE AGED; PEPTIC ULCER HEMORRHAGE; PNEUMONIA, VENTILATOR-ASSOCIATED; RESPIRATION CENTER; TAIWAN; TREATMENT OUTCOME; VENTILATOR WEANING; VERY ELDERLY;

AGED; AGED, 80 AND OVER; FEMALE; HUMANS; LANSOPRAZOLE; MALE; MIDDLE AGED; PEPTIC ULCER; PEPTIC ULCER HEMORRHAGE; PNEUMONIA, VENTILATOR-ASSOCIATED; PROSPECTIVE STUDIES; PROTON PUMP INHIBITORS; RESPIRATORY CENTER; TAIWAN; TREATMENT OUTCOME; VENTILATOR WEANING;

EID: 84958740463     PISSN: 09296646     EISSN: 18760821     Source Type: Journal    
DOI: 10.1016/j.jfma.2014.10.006     Document Type: Article

References (40)

1. Marik P.E., Vasu T., Hirani A., Pachinburavan M. Stress ulcer prophylaxis in the new millennium: a systematic review and meta-analysis. Crit Care Med 2010, 38:2222-2228.
2. Cook D.J., Fuller H.D., Guyatt G.H., Marshall J.C., Leasa D., Hall R., et al. Risk factors for gastrointestinal bleeding in critically ill patients. Canadian Critical Care Trials Group. N Engl J Med 1994, 330:377-381.
3. Laine L., Curtis S.P., Langman M., Jensen D.M., Cryer B., Kaur A., et al. Lower gastrointestinal events in a double-blind trial of the cyclo-oxygenase-2 selective inhibitor etoricoxib and the traditional nonsteroidal anti-inflammatory drug diclofenac. Gastroenterology 2008, 135:1517-1525.
4. Kuipers E.J., Sung J.J., Barkun A., Mossner J., Jensen D., Stuart R., et al. Safety and tolerability of high-dose intravenous esomeprazole for prevention of peptic ulcer rebleeding. Adv Ther 2011, 28:150-159.
5. Kahn J.M., Doctor J.N., Rubenfeld G.D. Stress ulcer prophylaxis in mechanically ventilated patients: integrating evidence and judgment using a decision analysis. Intensive Care Med 2006, 32:1151-1158.
6. Huang J., Cao Y., Liao C., Wu L., Gao F. Effect of histamine-2-receptor antagonists versus sucralfate on stress ulcer prophylaxis in mechanically ventilated patients: a meta-analysis of 10 randomized controlled trials. Crit Care 2010, 14:R194. 10.1186/cc9312.
7. Labenz J., Peitz U., Leusing C., Tillenburg B., Blum A.L., Borsch G. Efficacy of primed infusions with high dose ranitidine and omeprazole to maintain high intragastric pH in patients with peptic ulcer bleeding: a prospective randomized controlled study. Gut 1997, 40:36-41.
8. Daley R.J., Rebuck J.A., Welage L.S., Rogers F.B. Prevention of stress ulceration: current trends in critical care. Crit Care Med 2004, 32:2008-2013.
9. Barkun A.N., Adam V., Martel M., Bardou M. Cost-effectiveness analysis: stress ulcer bleeding prophylaxis with proton pump inhibitors, H2 receptor antagonists. Value Health 2013, 16:14-22.
10. Field S., Kelly S.M., Macklem P.T. The oxygen cost of breathing in patients with cardiorespiratory disease. Am Rev Respir Dis 1982, 126:9-13.
11. Bouachour G., Guiraud M.P., Gouello J.P., Roy P.M., Alquier P. Gastric intramucosal pH: an indicator of weaning outcome from mechanical ventilation in COPD patients. Eur Respir J 1996, 9:1868-1873.
12. Doglio G.R., Pusajo J.F., Egurrola M.A., Bonfigli G.C., Parra C., Vetere L., et al. Gastric mucosal pH as a prognostic index of mortality in critically ill patients. Crit Care Med 1991, 19:1037-1040.
13. Fiddian-Green R.G. Associations between intramucosal acidosis in the gut and organ failure. Crit Care Med 1993, 21:S103-S107.
14. Mythen M.G., Webb A.R. The role of gut mucosal hypoperfusion in the pathogenesis of postoperative organ dysfunction. Intensive Care Med 1994, 20:203-209.
15. Mohsenifar Z., Hay A., Hay J., Lewis M.I., Koerner S.K. Gastric intramural pH as a predictor of success or failure in weaning patients from mechanical ventilation. Ann Intern Med 1993, 119:794-798.
16. Magder S., Erian R., Roussos C. Respiratory muscle blood flow in oleic acid-induced pulmonary edema. J Appl Physiol 1986, 60:1849-1856.
17. Zandstra D.F., Stoutenbeek C.P. The virtual absence of stress-ulceration related bleeding in ICU patients receiving prolonged mechanical ventilation without any prophylaxis. A prospective cohort study. Intensive Care Med 1994, 20:335-340.
18. Steinberg K.P. Stress-related mucosal disease in the critically ill patient: risk factors and strategies to prevent stress-related bleeding in the intensive care unit. Crit Care Med 2002, 30:S362-S364.
19. Heffner J.E. Timing of tracheotomy in mechanically ventilated patients. Am Rev Respir Dis 1993, 147:768-771.
20. Cook D.J., Witt L.G., Cook R.J., Guyatt G.H. Stress ulcer prophylaxis in the critically ill: a meta-analysis. Am J Med 1991, 91:519-527.
21. Singh N., Rogers P., Atwood C.W., Wagener M.M., Yu V.L. Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription. Am J Respir Crit Care Med 2000, 162:505-511.
22. Mutlu G.M., Mutlu E.A., Factor P. GI complications in patients receiving mechanical ventilation. Chest 2001, 119:1222-1241.
23. Bruno J.J., Canada T.W., Wakefield C.D., Nates J.L. Stress-related mucosal bleeding in critically ill oncology patients. J Oncol Pharm Pract 2009, 15:9-16.
24. Schuster D.P., Rowley H., Feinstein S., McGue M.K., Zuckerman G.R. Prospective evaluation of the risk of upper gastrointestinal bleeding after admission to a medical intensive care unit. Am J Med 1984, 76:623-630.
25. Metz D.C. Preventing the gastrointestinal consequences of stress-related mucosal disease. Curr Med Res Opin 2005, 21:11-18.
26. Labattut A.G., De Andres A.P., Ortigosa A.M., Del Mar Gobernado Serrano M., Gimino O.L. Efficacy of sucralfate in the prevention of upper gastrointestinal stress bleeding in intensive care patients: comparison versus a control group. Clin Intensive Care 1992, 3(Suppl):S19-S25.
27. Tzong-Hsi Lee H.-T.C. Comparison of esomeprazole and sucralfate for stress ulcer prophylaxis. Gastroenterol J Taiw 2006, 23:80.
28. Cook D., Guyatt G., Marshall J., Leasa D., Fuller H., Hall R., et al. A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care Trials Group. N Engl J Med 1998, 338:791-797.
29. Conrad S.A., Gabrielli A., Margolis B., Quartin A., Hata J.S., Frank W.O., et al. Randomized, double-blind comparison of immediate-release omeprazole oral suspension versus intravenous cimetidine for the prevention of upper gastrointestinal bleeding in critically ill patients. Crit Care Med 2005, 33:760-765.
30. Devlin J.W., Welage L.S., Olsen K.M. Proton pump inhibitor formulary considerations in the acutely ill. Part 2: Clinical efficacy, safety, and economics. Ann Pharmacother 2005, 39:1844-1851.
31. Bell N.J., Hunt R.H. Time to maximum effect of lansoprazole on gastric pH in normal male volunteers. Aliment Pharmacol Ther 1996, 10:897-904.
32. Blum R.A., Shi H., Karol M.D., Greski-Rose P.A., Hunt R.H. The comparative effects of lansoprazole, omeprazole, and ranitidine in suppressing gastric acid secretion. Clin Ther 1997, 19:1013-1023.
33. Freston J., Chiu Y.L., Pan W.J., Lukasik N., Taubel J. Effects on 24-hour intragastric pH: a comparison of lansoprazole administered nasogastrically in apple juice and pantoprazole administered intravenously. Am J Gastroenterol 2001, 96:2058-2065.
34. Navab F., Steingrub J. Stress ulcer: is routine prophylaxis necessary?. Am J Gastroenterol 1995, 90:708-712.
35. Herzig S.J., Howell M.D., Ngo L.H., Marcantonio E.R. Acid-suppressive medication use and the risk for hospital-acquired pneumonia. JAMA 2009, 301:2120-2128.
36. Miano T.A., Reichert M.G., Houle T.T., MacGregor D.A., Kincaid E.H., Bowton D.L. Nosocomial pneumonia risk and stress ulcer prophylaxis: a comparison of pantoprazole versus ranitidine in cardiothoracic surgery patients. Chest 2009, 136:440-447.
37. Lin P.C., Chang C.H., Hsu P.I., Tseng P.L., Huang Y.B. The efficacy and safety of proton pump inhibitors versus histamine-2 receptor antagonists for stress ulcer bleeding prophylaxis among critical care patients: a meta-analysis. Crit Care Med 2010, 38:1197-1205.
38. Khamiees M., Raju P., DeGirolamo A., Amoateng-Adjepong Y., Manthous C.A. Predictors of extubation outcome in patients who have successfully completed a spontaneous breathing trial. Chest 2001, 120:1262-1270.
39. Esteban A., Alia I. Clinical management of weaning from mechanical ventilation. Intensive Care Med 1998, 24:999-1008.
40. Lemaire F. Difficult weaning. Intensive Care Med 1993, 19(Suppl. 2):S69-S73.